Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IMCD NVFRA:INX -1.88%89 Return-on-Tangible-Asset is 13.37% as of Jun. 2026, which is 4% above its 10-year median of 12.82. GuruFocus rates FRA:INX with a GF Score™ of 89/100 and a GF Value™ of €129.71 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 1,611 Chemicals companies, IMCD NV ranks better than 88.45% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. IMCD NV's annualizedNet Income for the quarter that ended in Jun. 2026 was €285 Mil. IMCD NV's average total tangible assets for the quarter that ended in Jun. 2026 was €2,130 Mil. Therefore, IMCD NV's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 13.37%.
The historical rank and industry rank for IMCD NV's Return-on-Tangible-Asset or its related term are showing as below:
FRA:INX'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 10.24 Med: 12.82 Max: 19.78
Current: 10.95
During the past 13 years, IMCD NV's highest Return-on-Tangible-Asset was 19.78%. The lowest was 10.24%. And the median was 12.82%.
FRA:INX's Return-on-Tangible-Asset is ranked better than 88.45% of 1611
companies
in the Chemicals industry
Industry Median: 3.09
vs FRA:INX: 10.95
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
IMCD NV Return-on-Tangible-Asset Related Terms
IMCD NV Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for IMCD NV's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:INX vs LIN, SHW, ECL: Return-on-Tangible-Asset Comparison
For the Specialty Chemicals subindustry, IMCD NV's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IMCD NV Return-on-Tangible-Asset vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, IMCD NV's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where IMCD NV's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 13.37% mean?
IMCD NV (FRA:INX) has a Return-on-Tangible-Asset of 13.37% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on IMCD NV and its competitors. This is near median its historical median of 12.82. Over the past decade, IMCD NV's Return-on-Tangible-Asset has ranged from 10.24 to 19.78. According to the industry distribution chart, IMCD NV ranks #186 out of 1611 companies in the Chemicals industry, placing it in the top 11.5%.
Is IMCD NV's Return-on-Tangible-Asset too high?
IMCD NV's current Return-on-Tangible-Asset of 13.37% is near median its 10-year median of 12.82. Over the past 10 years, this metric has ranged from a low of 10.24 to a high of 19.78. The Chemicals industry median Return-on-Tangible-Asset is 3.09. IMCD NV's value of 13.37% is 332.7% above this industry median. Based on the distribution chart, IMCD NV ranks #186 out of 1611 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, IMCD NV has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does IMCD NV's Return-on-Tangible-Asset compare to LIN and SHW?
According to the Chemicals industry distribution chart, IMCD NV ranks #186 out of 1611 companies for Return-on-Tangible-Asset. This places IMCD NV in the top 12% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 3.09. IMCD NV's value of 13.37% is 332.7% above this benchmark. Historically, IMCD NV's own Return-on-Tangible-Asset has ranged from 10.24 to 19.78 over the past decade. While the company's 10-year median is 12.82 vs. the industry median of 3.09, IMCD NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Chemicals company?
The median Return-on-Tangible-Asset among Chemicals companies is 3.09, based on 1,611 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IMCD NV's current Return-on-Tangible-Asset of 13.37% is 332.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on IMCD NV and its competitors. For the Chemicals industry, the median Return-on-Tangible-Asset is 3.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IMCD NV's current Return-on-Tangible-Asset is 13.37%, which is near median its own 10-year median of 12.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMCD NV stock overvalued right now?
Based on GuruFocus' analysis, IMCD NV (FRA:INX) is currently considered Modestly Undervalued. The stock's GF Value™ is €129.71, compared to a current price of €95.08 — trading 26.7% below its estimated fair value. The current Return-on-Tangible-Asset is 13.37%, which is near median its 10-year median of 12.82 and 332.7% above the Chemicals industry median of 3.09. IMCD NV's overall GF Score™ is 89/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For IMCD NV (FRA:INX), the current Return-on-Tangible-Asset is 13.37% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IMCD NV (FRA:INX) Overvalued in 2026?
Based on GuruFocus' analysis, IMCD NV stock appears to be undervalued.
The current stock price of €95.08 is trading 26.7% below its estimated GF Value™ of €129.71.
GuruFocus considers IMCD NV to be Modestly Undervalued.
Key valuation signals for FRA:INX:
Return-on-Tangible-Asset: 13.37% (near median its 10-year median of 12.82)
GF Value™: €129.71 vs. price of €95.08 (26.7% below fair value)
Industry Position: 332.7% above the Chemicals median (#186 of 1611)
No single metric tells the full story. See the FRA:INX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IMCD NV is a distributor and formulator of specialty chemicals and ingredients for industrial and life-science markets. The company's product portfolio consists of two categories: Life Science, which consists of the following lines of business: Pharmaceuticals, Beauty & Personal Care, Food & Nutrition, and Home Care I&I, and the Industrial segment, which contains the lines of business of Coatings & Construction, Lubricants & Energy, Industrial Solutions and Advanced Materials. The company has four operating segments: EMEA, Americas, Asia-Pacific, and Holding companies. It derives a majority of its revenue from the EMEA segment, which includes Europe, Turkiye, Israel, Egypt, the United Arab Emirates, Saudi Arabia and Africa.
89GF Score
Get the complete analysis for FRA:INX
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:INX has been successfully added to your 
